EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO)

This collaboration will ensure the continuity of API development, from route scouting to process industrialization and GMP manufacturing EUROAPI and SpiroChem to provide clients with consolidated CRO-CDMO customized solutions to accelerate API chemical development and shorten timelines, especially for early-stage projects and the biotech segment. This agreement will strengthen EUROAPI’s Contract…

EUROAPI UK switches on to renewable energy

Euroapi UK has switched on their solar farm, generating renewable energy to sustain the manufacturing facility for the next 30 years.

CDMO: EUROAPI completes acquisition of Biano

CDMO: EUROAPI completes acquisition of Biano

Paris – November 21, 2023 – EUROAPI today announced the completion of the acquisition of BianoGMP (“Biano”), strengthening its CDMO expertise in the high-growth oligonucleotide market.